Since innovation rhymes with technology, we put our know-how and 30 years of experience at the service of the manufacture of injectable medical devices.
We manufacture gels based on hyaluronan or other biopolymers and may incorporate APIs to improve their characteristics or performance.

We work with natural or modified polymers. We practice our own cross-linking modifications based on the IntexHya technology.

Our manufacturing skills can be illustrated by the following:

  • GMP manufacturing

    Our controlled manufacturing environment and good manufacturing practices ensure the level of safety required by the most demanding regulatory requirements.

  • Formulation

    Our formulation methods and batch sizes are sized on an economically viable scale, always guaranteeing a reliable, repeatable and economical result.

  • Fill & Finish

    We precisely master filling, candling, sterilization and packaging, which are intrinsic components of our manufacturing process.

  • Sterilization

    Our sterilization cycles are custom-developed and rigorously validated to achieve the targeted product performances while guaranteeing the sterility of medical devices.

  • Analytical Controls

    We rigorously analyze the physicochemical properties of your products to certify compliance, at the end and throughout the manufacturing process.

  • Quality

    Swiss quality is around the corner at every stage of our supply chain, framed by a quality management system certified ISO 13485 by SGS in Geneva.

We manufacture your product

Value-added technology

Our choice is to rely on high quality hyaluronic acid, of natural origin or modified by cross-linking, always highly purified. When combined with our proprietary manufacturing technology, we are confident in the added value we bring to the development and implementation of your products.

Syrhatech - assets

We rely on strong skills and experience to provide you with medical devices of high performance and safety. Like hyaluronic acid, other biopolymers can be integrated into our manufacturing processes after a controlled and rigorous process of technical transfer, customization of the formulation, industrialization and validation.

Explore our environment

  • Company

    SyrHATech goes to CPHI Barcelona – from 10/24 to 10/26

    The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant…

    CPHI Barcelona 2023
  • Company

    Inauguration of Syrhatech’s new premises in Geneva

    The Syrhatech team was delighted to share a convivial moment on its terrace on the…

    Inauguration of Syrhatech's new premises in Geneva
  • Company

    Development of a specific syringe for wrinkle filler

    Our customer contacts us to validate the design of a syringe made of plastic by…

  • Company

    Development of an innovative gel with very high concentration

    Our client contacts us to industrialize a new manufacturing technique, compatible with the objectives of…

  • Company

    Technology transfer

    Our team relies on its many years of experience and past successes, to prepare and…

    Syrhatech - technology transfer
  • Company

    Development of a cross-linked HA formulation containing peptides

    At the request of our customer, this cross-linked HA product incorporates peptides for various therapeutic…

    Syrhatech - Value added technology
  • Company

    Development of a cross-linked hydrogel similar to an existing product

    Reverse engineering and formulation of cross-linked HA for specific (non-aesthetic) applications, and development of steam…

  • Company

    Formulation of a new polymer

    Technology transfer and development of a manufacturing process for a polysaccharide other than hyaluronic acid…

    Syrhatech - Who are we ?